The REMOVAL trial: metformin reduces progression of mean carotid intima-media thickness (cIMT) in non-smokers with Type 1 diabetes

被引：0
|
作者：
Petrie, J. R. [1 ]
Chaturvedi, N. [2 ]
Hughes, A. D. [2 ]
Tillin, T. [2 ]
Greenlaw, N. [3 ]
Ford, I. [3 ]
Sattar, N. [1 ]
Colhoun, H. M. [4 ]
机构：
[1] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[2] UCL, Inst Cardiovasc Sci, London, England
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[4] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland
来源：
DIABETIC MEDICINE | 2019年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P44
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] The REMOVAL trial: metformin reduces progression of mean carotid intima-media thickness (cIMT) in never smokers with type 1 diabetes
    Petrie, J. R.
    Chaturvedi, N.
    Ford, I.
    Brouwers, M. C. G.
    Greenlaw, N.
    Hramiak, I.
    Hughes, A. D.
    Jenkins, A. J.
    Klein, B. E. K.
    Klein, R.
    Rossing, P.
    Stehouwer, C. D. A.
    Sattar, N.
    Colhoun, H. M.
    DIABETOLOGIA, 2018, 61 : S555 - S555
  • [2] Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial
    Timmons, Joseph G.
    Greenlaw, Nicola
    Boyle, James G.
    Chaturvedi, Nish
    Ford, Ian
    Brouwers, Martijn C. G. J.
    Tillin, Therese
    Hramiak, Irene
    Hughes, Alun D.
    Jenkins, Alicia J.
    Klein, Barbara E. K.
    Klein, Ron
    Ooi, Teik C.
    Rossing, Peter
    Stehouwer, Coen D. A.
    Sattar, Naveed
    Colhoun, Helen M.
    Petrie, John R.
    DIABETES OBESITY & METABOLISM, 2021, 23 (06): : 1371 - 1378
  • [3] Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes
    Mita, Tomoya
    Watada, Hirotaka
    Ogihara, Takeshi
    Nomiyama, Takashi
    Ogawa, Osamu
    Kinoshita, Junichiro
    Shimizu, Tomoaki
    Hirose, Takahisa
    Tanaka, Yasushi
    Kawamori, Ryuzo
    ATHEROSCLEROSIS, 2007, 191 (01) : 162 - 167
  • [4] Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes
    Mita, T
    Watada, H
    Kawamori, R
    CIRCULATION, 2005, 112 (17) : U894 - U894
  • [5] Progression of the carotid artery intima-media thickness in young patients with type 1 diabetes
    Frost, D
    Beischer, W
    DIABETES CARE, 2003, 26 (02) : 545 - 545
  • [6] Carotid intima-media thickness in type 1 diabetes mellitus
    Koz, Cem
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (01): : 59 - 60
  • [7] α-Glucosidase inhibitor reduces the progression of carotid intima-media thickness
    Yamasaki, Y
    Katakami, N
    Hayaishi-Okano, R
    Matsuhisa, M
    Kajimoto, Y
    Kosugi, K
    Hatano, M
    Hori, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (03) : 204 - 210
  • [8] Effect of three insulin regimens on carotid intima-media thickness in patients with type 2 diabetes: the randomised Copenhagen Insulin and Metformin herapy (CIMT) trial
    Lundby-Christensen, L.
    DIABETOLOGIA, 2014, 57 : S516 - S516
  • [9] FEMORAL AND AORTIC INTIMA-MEDIA THICKNESS BUT NOT CAROTID OR BRACHIAL INTIMA-MEDIA THICKNESS ARE ABNORMAL IN CHILDREN WITH TYPE 1 DIABETES
    Lilje, C.
    Cardinale, J. P.
    Cronan, J.
    Kashyap, L.
    Clesi, P.
    Oral, E.
    Gomez, R.
    Hempe, J.
    Chalew, S.
    CARDIOLOGY, 2015, 131 : 179 - 179
  • [10] Carotid artery intima-media thickness in children with type 1 diabetes
    Järvisalo, MJ
    Putto-Laurila, A
    Jartti, L
    Lehtimäki, T
    Solakivi, T
    Rönnemaa, T
    Raitakari, OT
    DIABETES, 2002, 51 (02) : 493 - 498
12345